Clinical Trials · NCT05119179

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

Phase
Phase 4
Recruitment status
Recruiting
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
300
Start date
Nov 2021
Locations
1 site, United States
Primary endpoint
Mean change in beta cell responsivity
View Semaglutide compound reference